Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors

Kiyosumi Shibata, F. Kikkawa, M. Mika, Y. Suzuki, H. Kajiyama, K. Ino, S. Mizutani

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors'. Together they form a unique fingerprint.

Medicine & Life Sciences